Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002394214 | SCV002674340 | likely benign | Cardiovascular phenotype | 2022-09-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004526197 | SCV005040614 | likely benign | not specified | 2024-03-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005215860 | SCV005854811 | likely benign | Myofibrillar myopathy 6; Dilated cardiomyopathy 1HH | 2024-12-10 | criteria provided, single submitter | clinical testing |